Evidence map›Paper›PMID 34042523›Full record

ArticleDiabetes technology & therapeutics2021

Youth with Type 1 Diabetes Had Improvement in Continuous Glucose Monitoring Metrics During the COVID-19 Pandemic.

Fatema S Abdulhussein, Hannah Chesser, W John Boscardin, Stephen E Gitelman, Jenise C Wong

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diabetes technology & therapeutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Sustained Improvement in Glycemic Control in Emerging Adults with Type 1 Diabetes 2 Years After the Start of the COVID-19 Pandemic.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2023
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Fatema S AbdulhusseinDivision of Endocrinology, Department of Pediatrics, Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA.
Hannah ChesserDivision of Endocrinology, Department of Pediatrics, Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA.ORCID 0000-0002-0724-4310
W John BoscardinDepartment of Medicine, Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA.
Stephen E GitelmanDivision of Endocrinology, Department of Pediatrics, Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA.
Jenise C WongDivision of Endocrinology, Department of Pediatrics, Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA.
University of California, San Francisco · US

Funding

Training Program in Pediatric EndocrinologyT32DK007161 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Brian J Feldman, STEPHEN E GITELMAN · 1986 to 2026
$6.2M
NIDDK NIH HHS T32 DK007161
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Diabetes Mellitus, Type 1AdolescentAdultBlood GlucoseBlood Glucose Self-MonitoringChildChild, PreschoolGlucoseHumansPandemicsRetrospective StudiesSARS-CoV-2Young AdultBlood GlucoseGlucoseContinuous glucose monitoringCOVID-19PediatricsTime in rangeType 1 diabetes

Identifiers

PMID34042523
PMCPMC8573792
OpenAlexW3165219540

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.